Both in Pharmaceuticals
Artelo Biosciences vs Valion Bio
Over the past year ARTL returned −60.0% and VBIO returned −76.5%; their daily moves had a correlation of 0.07.
ARTL −60.0% VBIO −76.5%Growth of $1, one year, split-adjusted
| Metric | ARTL | VBIO |
|---|---|---|
| Price | $2.17 | $0.5309 |
| Market cap | $1.2M | $1.1M |
| Today | −2.25% | −3.47% |
| 1 month | −41.0% | −79.5% |
| 6 months | −92.7% | — |
| Year to date | −93.4% | — |
| 1 year | −97.4% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $4.2M | -$5.3M |
| Dividend yield | — | — |
| Volatility (60d) | 650.2% | — |
| Short % of float | 0.8% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).